Talk:Eugeroic
| This is the talk page for discussing improvements to the Eugeroic article. This is not a forum for general discussion of the article's subject. |
Article policies
|
| Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL |
 | This article is rated Start-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | |||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||
Merger Proposal edit
As somebody mentioned a year ago in the other talk page, this is a pretty obvious merge. TachyonJack (talk) 20:15, 3 April 2013 (UTC)
Imported talk page sections from Talk:Wakefulness-promoting agent edit
Proposed merge edit
There is no reason that this article should not be merged with the article on Eugeroics as that is the name of the category in the Stimulant box. — Preceding unsigned comment added by 207.251.103.42 (talk) 20:13, 2 March 2012 (UTC)
I have completed the merge and, as per WP:COMMONNAME merged into this article. LT90001 (talk) 03:35, 9 October 2013 (UTC)
Drug Examples 2C-G-N removed edit
The text removed is found below
Other drugs:
- 2C-G-N (causes wakefulness for 20 to 30 hours) [verification needed]
Given that this is described to have amphetamine like effects, and was only synthesized and tested by a very small group of individuals, it is very dubious to have this stated as an example of a eugeroic. The description that this compound is amphetamine like, on its page, should be enough to warrant removal as the whole point of wakefulness promoting agents is to NOT have such effects.
orexin edit
moved here per WP:PRESERVE as this was unsourced:
The main mechanism of action of wakefulness enhancers(eugeroics) come from activation of orexin receptors(orexin receptor agonist), which causes an increase in histamine levels.
The functional opposites of wakefulness-promoting agents are hypnotics, such as centrally-acting antihistamines (H1 receptor antagonists) and suvorexant, an orexin receptor antagonist.